CompletedNCT04505189
Psilocybin for Anorexia: Pilot Study
About this title
Read the official source — NCT04505189Medication studyAges 21–65United KingdomEating disorders
Understand this study
Who was this study for?
Listed age limits: 21 years to 65 years.
- Listed locations
- LondonSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: May 28, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 21
- Sponsor
- Imperial College London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United Kingdom
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT04505189
- Official title
Show the full official title
Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Imperial College London, a university.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin.
Who was this study for?
Listed age limits: 21 years to 65 years.
